Position in VERU
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$22,100
+$690 QoQ
Shares Held
10,000
-0.0% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VERU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO holds $27,227,727 across 141 Biotechnology names. VERU ranks #41 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
49,020 | $5,166,708 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,856 | $3,954,558 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,053 | $3,131,509 | |
| 4 | INCY |
Incyte Corp
|
32,727 | $3,080,265 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,761 | $2,189,608 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
9,815 | $1,855,525 | |
| 7 | RPRX |
Royalty Pharma plc
|
29,981 | $1,438,188 | |
| 8 | MRNA |
Moderna, Inc.
|
19,187 | $974,699 |
All Filings in VERU
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,100 | 10,000 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $21,410 | 10,005 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $38,000 | 10,000 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||